Quick Takeaways
- This page summarizes Daniel Char's Form 4 filing for ImmunoGen, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 05 Feb 2024, 21:28.
Daniel Char - 01 Feb 2024 Form 4 Insider Report for ImmunoGen, Inc.
- Signature
- /s/ Renee Lentini, Attorney-in-Fact
- Issuer symbol
- N/A
- Transactions as of
- 01 Feb 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 05 Feb 2024, 21:28:20 UTC
- Previous filing
- 30 Nov 2022
- Next filing
- 12 Feb 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Daniel Char filed Form 4 for ImmunoGen, Inc. on 05 Feb 2024."
What Changed
- Previous filing in this sequence was filed on 30 Nov 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMGN | Restricted Stock Unit | Award | $0 | +22,825 | $0.000000 | 22,825 | 01 Feb 2024 | Common Stock | 22,825 | $0.000000 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. |
| F2 | The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date. |